«Lung Cancer in the Age of Innovation
The importance of early screening, new therapeutic approaches – a modern approach to molecular testing and clinical studies»
Wednesday, 23th of November 2022 – B&E Goulandris Foundation
FairLife L.C.C, the first non-profit social organization in Greece, exclusively dedicated to lung cancer, is hosting its annual conference entitled “Lung Cancer in the Age of Innovation: The importance of early screening, new therapeutic approaches – a modern approach to molecular testing and clinical studies”
The conference will be hosted on Wednesday, 23th of November 2022 at the B&E Goulandris Foundation. November is Lung Cancer Awareness Month and the conference will be held in the course of actions to promote lung cancer awareness in society and the state, on prevention, early diagnosis and the latest scientific developments, regarding the treatment and management of the disease.
The conference topics to be discussed will be early screening, molecular identification of tumors, the latest developments in clinical studies and the rapid development of new treatments, which save thousands lives.
The event will be coordinated and presented by journalist Elena Papadimitriou.
More than 50 representatives from the scientific, academic and research community in Greece and abroad, representatives of the Greek State and patients as well as pharmaceutical industry executives will participate as speakers and commentators. They are asked to comment on the value of innovation, the role of medical precision and personalised treatment against Lung Cancer and to answer crucial questions, concerning patients. On the part of the State, as a strategic priority and a public health issue, as a field of innovation, for research, a race against time, supported by modern therapeutic approaches and the medical and pharmaceutical community.
The event will be addressed by : Mr. Thanos Plevris, Minister of Health, Athanasios Meletios Dimopoulos, Rector of the National and Kapodistrian University of Athens, Professor of Hematology-Oncology, Konstantinos Syrigos, Professor and Director of the School of Medicine, National and Kapodistrian University of Athens, Prof. Sanjay Popat, Professor of Thoracic Oncology, Dr. Karen Kelly, CEO International Association for the Study of Lung Cancer (IASLC) and Ewelina Szmytke, Vice President, Lung Cancer Europe.
In reference to the conference, Mrs. Korina Pateli- Bell, President of FairLife LCC, noted: “Lung cancer unfortunately remains the most common and most lethal neoplasm today. However, it is also a field of significant progress, as innovation changes landscape, bringing hope to so many patients. Our distinguished speakers and commentators, who honor us with their presence, will provide answers to crucial questions, regarding patients.”
The event is held under the auspices of the scientific companies: Hellenic Society of Medical Oncology (HeSMO), Hellenic Thoracic Society (HTS), Hellenic Association of Lung Cancer (HeALC), Hellenic Society of Thoracic and Cardiovascular Surgeons (HCTSS), Hellenic Society of Radiation Oncology (HESRO), ) Hellenic Radiological Society (HELRAD.), Hellenic Society of Pathological Anatomy (H.E.P.A.), Hellenic Foundation for Cancer Research (H.F.C.R.) And of the European and international bodies, Global Lung Cancer Coalition (GLCC), International Association for the Study of Lung Cancer (IASLC), Lung Cancer Europe (LuCE), Lung Ambition Alliance (LAA), Lung Cancer Awareness Month Coalition (LCAM) and the the Hellenic Association of Pharmaceutical Companies (S.F.Ε.Ε) and PhRMA Innovation Forum (PIF).
The conference is supported by: Roche Hellas (Distinguished Sponsor), MSD (Grand Sponsor), AstraZeneca Greece, Amgen Hellas, BMS Greece , Janssen-Cilag (Sponsors), Pfizer Hellas, Pharmaserve-Lilly S.A.C.I., Sanofi, Ipsen, Takeda (Supporters).
Simultaneous interpretation (Greek-English) as well as in Greek Sign Language will be available at the conference.
AGENDA
10.00 – 10.45 EET
Opening address – Greetings
Korina Pateli Bell, President of FairLife Lung Cancer Care
Thanos Plevris, Minister of Health
Mina Gaga, Deputy Minister of Health
Athanasios-Meletios Dimopoulos, Rector of the National and Kapodistrian University of Athens
Professor Sanjay Popat (PhD FRCP), Consultant Medical Oncologist, Royal Marsden Hospital, Professor of Thoracic Oncology,Institute of Cancer Research
Konstantinos Syrigos(MD, PhD, FCCP),Professor & Director Medical School of Athens, National & Kapodistrian University of Athens
Karen Kelly (MD), CEO IASLC, Professor Emeritus University of California, Davis
Ewelina Szmytke, Vice President, LUCE
10.45 – 11.25 EET
INTRODUCTION
One year later: Are we ready for the Screening programme?
Evi Hatziandreou (MD, DrPH), Dr. of Public Health, University of Harvard, Vice President of FairLife LCC
Kyriakos Souliotis, Professor of Health Policy, Dean of the Faculty of Social and Political Sciences, University of Peloponnese
Helena Linardou (MD, PhD), Medical Oncologist, Director of the 4th Oncology Clinic – Metropolitan Hospital, President of the Scientific Committee of HeCOG (HeLLENIC COΟPERATIVE ONCOLOGY GROUP)
Commentary discussion
Eirini Agapidaki, General Secretary, Ministry of Health
Stelios Loukidis (MD, FCCP, FERS), Professor of Respiratory Medicine, National and Kapodistrian University of Athens, President of the Hellenic Thoracic Society (HTS)
11.25 – 11.30 EET
Break
11.30 – 12.40 EET
SECTION A
A modern approach to molecular screening – The role of precision medicine in lung cancer and its value for patients
Comprehensive genomic profiling (CGP) – New technologies in molecular identification of tumors (challenges – best practices)
Petros Christopoulos (MD, PhD) (11:30-11:45)
Medical Oncologist & Hematologist, Professor of Pathological Oncology, Heidelberg University
Liquid biopsy: clinical applications (present and future) – The role of repeat biopsy
Evi Lianidou (PhD) (11:45-12:00)
Professor of Analytical Chemistry – Clinical Chemistry Department of Chemistry, National and Kapodistrian University of Athens
Adoption, reimbursement status, challenges and prospects
Theofanis Rigatos (12:00-12:15)
Head of the Independent Directorate of Contracts and Vendor Auditing, National Organization for Health Care Services Provision (EOPPY)
Commentary discussion:
12:15 – 12:35
Zenia Saridaki (MD, PhD), Medical Oncologist, President of the Hellenic Society of Medical Oncology (HeSMO)
Aphrodite Nonni (MD), Pathologist, President of the Hellenic Society of Pathology (HSP)
Kathi Apostolidis,President Hellinic Cancer Federation – ELLOK – ECPC Past President – Chair Scientific Committee.
12:35 – 12:50 EET
Break
12.35 – 12.50 EET
Break
12:50 – 14:20 EET
SECTION B
Personalized therapies in modern treatment of lung cancer – Facts and new approaches
ALK
Athina Christopoulou (MD, Ph.D) (12:50-13:00)
Medical Oncologist, Director of Oncology Unit, General Hospital of Patras
EGFR – EXON20
George Lainakis (MD) (13:00-13:10)
Medical Oncologist, Deputy Head of the 4th Oncology Department, Metropolitan Hospital
KRAS
Ferdinandos Skoulidis (MD, PhD, MRCP) (13:10-13:20)
Head and Neck Medical Oncology Division Cancer Medicineut MD Anderson Cancer Center, Department Of Thoracic-Head & Neck Med Onc.
BRAF , HER2 , MET
Michalis Liontos (MD, PhD) (13:20-13:30)
Medical Oncologist, Assistant Professor at the Department of Clinical Therapeutics, Oncology Unit, Alexandra Hospital, National and Kapodistrian University of Athens
ROS 1 , RET , NTRK
Maria Skondra (MD) (13:30-13:40)
Medical Oncologist Registrar, 3rd Internal Medicine-Oncology Clinic, Henry Dunant Hospital
TILs, Tumor Infiltrating Lymphocytes στον NSC Lung Cancer; delivering the therapy at the Point of Care.
Evi Hatziandreou (MD, DrPH) (13:40-13:50)
Sr. Director, Health Policy and Market Access. Theracell Advanced Biotechnology, Vice President of FairLife LCC
Commentary discussion:
13:50-14:15
Paraskevi Katsaounou (MD), Pulmonologist, Associate Professor of Pulmonary Medicine, School of Medicine, National and Kapodistrian University of Athens
Anna Batistatou (MD, PhD),Professor of Pathology, Director of the Department of Pathology UOI and of the Pathology/Cytology Laboratory UHI, University of Ioannina, Greece
Ioannis Boukovinas (MD, PhD, PharmaD), Medical Oncologist, Scientific Manager of Medical Oncology Unit at Bioclinic Thessaloniki
Epaminondas Samantas (MD, PhD), Medical Oncologist, Director of the 2nd Oncology Department, Metropolitan Hospital
14.15 – 14.50 EET
Lunch Break
14.50 – 16.10 EET
SECTION C
New therapeutic approaches
The role of immunotherapy in early-stage NSCLC
Ioannis Mountzios (MD, MSc, PhD) (14:50-15:05)
Medical Oncologist, Director 4th Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center
The contribution of immunotherapy to metastatic NSCLC
Ilias Athanasiadis (MD) (15:05-15:20)
Medical Oncologist, Director of the Oncology Clinic, Mitera Hospital
Digital applications for cancer: National Registry, Treatment Protocols, Oncological File
Panagiota Mitrou (15:20-15:35)
Head of Independent Department of Therapeutic Protocols and Patient Registries
Ministry of Health
Patient view – Lived experience
Christos Apostolakos (15:35-15:40)
Commentary discussion:
15:40-16:10
Dimitra Kanaloupiti (MD), Medical Oncologist, Director of the 4th Oncology Clinic, Iaso Hospital
Paris Kosmidis (MD), Medical Oncologist, Director of the 2nd Internal Medicine-Oncology Clinic, Ygeia Hospital
Anastasios Boutis (MD), Medical Oncologist, Theagenio Cancer Hospital, Thessaloniki, General Secretary of HeSMO
Zoi Grammatoglou, President of the KEFI Association (Association of Cancer Patients, Volunteers, Friends and Doctors of Athens)
16.00 – 16.15 EET
Break
SECTION D
Clinical Research
Clinical studies, present and future
Helena Linardou (MD, PhD) (16:15-16:30)
Medical Oncologist, Director of the 4th Oncology Clinic – Metropolitan Hospital, President of the Scientific Committee of HeCOG
Academic research facts
Amanda Psyrri (MD, PhD, FACP) (16:30-16:45)
Professor of internal medicine and medical oncology Chairman,2nd Department of internal medicine, ATTIKON university hospital
Regulatory framework, challenges and prospects
Dimitris Philippou (16:45-17:00)
General Surgeon, Assistant Professor of Anatomy, National & Kapodistrian University of Athens,
President of the National Organization for Medicines (EOF)
Lived experience
George Siaravas (17:00-17:05)
Patient advocate, Ambassador ICAN
Patients Advocacy (17:05-17:20)
Janet Freeman Daily, Co-Founder President, Board Chair – The ROS1ders, Inc
Terri Conneran, Founder of KRASKickers
Lindi Campbell, President Breath of Hope KY, Inc.
The role of pharmaceutical industry
Roche Hellas
Konstantinos Poulimenos
Head of the Clinical Trial Operations Department
AstraZeneca Greece
Christos Antonopoulos (MD, PhD, EMBA)
Director of the Oncology-Hematology Business Unit
Amgen
Periklis Giovas (MD, PhD)
Medical Director
BMS Greece
Zefi Vlachopioti
Market Access Lead
Janssen
Dimitris Stathopoulos (MD, MSc, PhD)
Therapeutic Area Lead Oncology/Hematology/PAH
Commentary discussion:
17:50 – 18:15
Nikos Dedes, President of the Greek Patient Association
Kyriakos Souliotis, Professor of Health Policy, Dean of the Faculty of Social and Political Sciences, University of Peloponnese
Caius Kim, Global Director,AstraZeneca,Lung Ambition Alliance
Andrew Ciupek (PhD) Associate Director, Clinical Research GO2 Foundation
Amy Moore (PhD) VP, Global Engagement and Patient Partnerships LUNGevity Foundation
18.15 – 18.30 EET
Closing address, Conclusions
Presentation – Coordination: Elena Papadimitriou, Journalist
The wider public can join the conference in person or remotely, through FairLife LCC’s Facebook and ΥouTube channels, by registering at the following link:https://fairlifelcc.com/en/lung-cancer-in-the-age-of-innovation/registration/
Detailed information about the conference:https://fairlifelcc.com/en/lung-cancer-in-the-age-of-innovation/
For more information:
Communication Manager
FairLife L.C.C.:
Nelly Kapsi
Napoleontos 18, 16675, Glyfada
Τηλ: 213 0165784
FairLine 111 57 – Information Line
Email: info@fairlifelcc.com
Facebook: https://www.facebook.com/fairlifelcc
Website: https://fairlifelcc.com/
Instagram: https://www.instagram.com/fairlifelcc/
YouTube: https://www.youtube.com/channel/UCxv4C1yQoBQOITPKjk6JY3A
Twitter: https://twitter.com/fairlifelcc
LinkedIn: https://www.linkedin.com/company/71197914/admin/
Athens, 16/11/2022